Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.090
+0.060 (2.96%)
Apr 17, 2025, 4:00 PM EDT - Market open
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $28.67 million as of April 21, 2025. Its market cap has decreased by -9.75% in one year.
Market Cap
28.67M
Enterprise Value
17.62M
1-Year Change
-9.75%
Ranking
Category
Stock Price
2.09
Market Cap Chart
Since October 24, 2011, Grace Therapeutics's market cap has decreased from $87.20M to $28.67M, a decrease of -67.12%. That is a compound annual growth rate of -7.91%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.27B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.48B |
| AbbVie | 306.02B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.16B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |